The Antianginal Agent, Ranolazine, Reduces Myocardial...

The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit

Hale, S. L., Kloner, R. A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Cardiovascular Pharmacology and Therapeutics
DOI:
10.1177/1074248408320278
Date:
May, 2008
File:
PDF, 159 KB
english, 2008
Conversion to is in progress
Conversion to is failed